🇺🇸 Vitamin D3 cholecalciferol) in United States

52 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 10 reports (19.23%)
  2. Dyspnoea — 6 reports (11.54%)
  3. Fatigue — 6 reports (11.54%)
  4. Nausea — 6 reports (11.54%)
  5. Anxiety — 4 reports (7.69%)
  6. Asthenia — 4 reports (7.69%)
  7. Back Pain — 4 reports (7.69%)
  8. Dizziness — 4 reports (7.69%)
  9. Pneumonia — 4 reports (7.69%)
  10. Urinary Tract Infection — 4 reports (7.69%)

Source database →

Vitamin D3 cholecalciferol) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Vitamin D3 cholecalciferol) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Vitamin D3 cholecalciferol) in United States?

Abramson Cancer Center at Penn Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.